Skip to main navigation Skip to search Skip to main content

Pre-Clinical Assessment of PLK1 Inhibitors for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Associated Squamous Cell Carcinoma

Project Details

StatusFinished
Effective start/end date1/11/1131/10/13